IDEXX LABORATORIES INC /DE Increase (Decrease) in Other Operating Assets
IDEXX LABORATORIES INC /DE (IDXX) reported Increase (Decrease) in Other Operating Assets of -$41.04 million for the 9-month period ending 2015-09-30, per its 10-Q filed 2015-10-28.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2015-10-28
- IDEXX LABORATORIES INC /DE increase (decrease) in other operating assets for the quarter ending 2015-09-30 was -$8.25M, a 2040.94% decline year-over-year.
- IDEXX LABORATORIES INC /DE increase (decrease) in other operating assets for the quarter ending 2015-06-30 was -$17.31M, a 506.22% decline year-over-year.
- IDEXX LABORATORIES INC /DE increase (decrease) in other operating assets for the quarter ending 2015-03-31 was -$15.48M.
- IDEXX LABORATORIES INC /DE increase (decrease) in other operating assets for the quarter ending 2014-12-31 was $21.70M, a 139.97% increase year-over-year.
- IDEXX LABORATORIES INC /DE increase (decrease) in other operating assets for fiscal 2014 was $25.07M, a 479.72% increase from fiscal 2013.
- IDEXX LABORATORIES INC /DE increase (decrease) in other operating assets for fiscal 2013 was $4.33M.
- IDEXX LABORATORIES INC /DE increase (decrease) in other operating assets for fiscal 2012 was -$3.93M, a 393.73% decline from fiscal 2011.
- IDEXX LABORATORIES INC /DE increase (decrease) in other operating assets for fiscal 2011 was $1.34M, a 89.86% decline from fiscal 2010.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 3 month as first filed | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 6 month as first filed | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 9 month as first filed | Increase (Decrease) in Other Operating Assets 12 month |
|---|---|---|---|---|---|---|---|
| 2015-09-30 | -$8.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-28 | -$25.56M derived: sum of 2 quarters · filed 2015-10-28 | -$41.04M 10-Q · filed 2015-10-28 | -$19.34M derived: sum of 4 quarters · filed 2015-10-28 | |||
| 2015-06-30 | -$17.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | -$32.79M 10-Q · filed 2015-07-30 | -$11.09M derived: sum of 3 quarters · filed 2015-07-30 | -$10.67M derived: sum of 4 quarters · filed 2015-10-28 | |||
| 2015-03-31 | -$15.48M 10-Q · filed 2015-04-28 | $6.22M derived: sum of 2 quarters · filed 2015-04-28 | $6.64M derived: sum of 3 quarters · filed 2015-10-28 | $10.91M derived: sum of 4 quarters · filed 2015-10-28 | |||
| 2014-12-31 | $21.70M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | $22.12M derived: sum of 2 quarters · filed 2015-10-28 | $26.39M derived: sum of 3 quarters · filed 2015-10-28 | $25.07M 10-K · filed 2015-02-17 | |||
| 2014-09-30 | $425.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-28 | $4.69M derived: sum of 2 quarters · filed 2015-10-28 | $3.38M 10-Q · filed 2015-10-28 | $12.42M derived: sum of 4 quarters · filed 2015-10-28 | |||
| 2014-06-30 | $4.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | $2.95M 10-Q · filed 2015-07-30 | $11.99M derived: sum of 3 quarters · filed 2015-07-30 | $11.68M derived: sum of 4 quarters · filed 2015-07-30 | |||
| 2014-03-31 | -$1.31M 10-Q · filed 2015-04-28 | $7.73M derived: sum of 2 quarters · filed 2015-04-28 | $7.42M derived: sum of 3 quarters · filed 2015-04-28 | $9.31M derived: sum of 4 quarters · filed 2015-04-28 | |||
| 2013-12-31 | $9.04M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | $8.73M derived: sum of 2 quarters · filed 2015-02-17 | $10.63M derived: sum of 3 quarters · filed 2015-02-17 | $4.33M 10-K · filed 2015-02-17 | |||
| 2013-09-30 | -$310.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-24 | $1.58M derived: sum of 2 quarters · filed 2014-10-24 | -$4.72M 10-Q · filed 2014-10-24 | -$8.11M derived: sum of 4 quarters · filed 2015-02-17 | |||
| 2013-06-30 | $1.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-25 | -$4.41M 10-Q · filed 2014-07-25 | -$7.80M derived: sum of 3 quarters · filed 2015-02-17 | -$11.18M derived: sum of 4 quarters · filed 2015-02-17 | |||
| 2013-03-31 | -$6.30M 10-Q · filed 2014-04-25 | -$9.70M derived: sum of 2 quarters · filed 2015-02-17 | -$13.07M derived: sum of 3 quarters · filed 2015-02-17 | -$13.40M derived: sum of 4 quarters · filed 2015-02-17 | |||
| 2012-12-31 | -$3.39M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | -$6.77M derived: sum of 2 quarters · filed 2015-02-17 | -$7.10M derived: sum of 3 quarters · filed 2015-02-17 | -$3.93M 10-K · filed 2015-02-17 | |||
| 2012-09-30 | -$3.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-22 | -$3.70M derived: sum of 2 quarters · filed 2013-10-22 | -$539.00K 10-Q · filed 2013-10-22 | $3.86M derived: sum of 4 quarters · filed 2014-02-18 | |||
| 2012-06-30 | -$329.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-23 | $2.84M 10-Q · filed 2013-07-23 | $7.23M derived: sum of 3 quarters · filed 2014-02-18 | $11.47M derived: sum of 4 quarters · filed 2014-02-18 | |||
| 2012-03-31 | $3.17M 10-Q · filed 2013-04-23 | $7.56M derived: sum of 2 quarters · filed 2014-02-18 | $11.80M derived: sum of 3 quarters · filed 2014-02-18 | $11.05M derived: sum of 4 quarters · filed 2014-02-18 | |||
| 2011-12-31 | $4.39M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-18 | $8.63M derived: sum of 2 quarters · filed 2014-02-18 | $7.88M derived: sum of 3 quarters · filed 2014-02-18 | $1.34M 10-K · filed 2014-02-18 | |||
| 2011-09-30 | $4.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-19 | $3.49M derived: sum of 2 quarters · filed 2012-10-19 | -$3.06M 10-Q · filed 2012-10-19 | $4.32M derived: sum of 4 quarters · filed 2013-02-19 | |||
| 2011-06-30 | -$747.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-20 | -$7.29M 10-Q · filed 2012-07-20 | $79.00K derived: sum of 3 quarters · filed 2013-02-19 | $4.28M derived: sum of 4 quarters · filed 2013-02-19 | |||
| 2011-03-31 | -$6.55M 10-Q · filed 2012-04-20 | -$2.66M 10-Q · filed 2011-04-21 | $826.00K derived: sum of 2 quarters · filed 2013-02-19 | $5.03M derived: sum of 3 quarters · filed 2013-02-19 | $8.10M derived: sum of 4 quarters · filed 2013-02-19 | ||
| 2010-12-31 | $7.37M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-19 | $11.57M derived: sum of 2 quarters · filed 2013-02-19 | $14.65M derived: sum of 3 quarters · filed 2013-02-19 | $13.21M 10-K · filed 2013-02-19 | |||
| 2010-09-30 | $4.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-21 | $7.28M derived: sum of 2 quarters · filed 2011-10-21 | $5.84M 10-Q · filed 2011-10-21 | -$5.84M 10-Q · filed 2010-10-22 | $16.80M derived: sum of 4 quarters · filed 2012-02-17 | ||
| 2010-06-30 | $3.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-22 | $1.63M 10-Q · filed 2011-07-22 | -$1.63M 10-Q · filed 2010-07-23 | $12.60M derived: sum of 3 quarters · filed 2012-02-17 | $12.24M derived: sum of 4 quarters · filed 2012-02-17 | ||
| 2010-03-31 | -$1.44M 10-Q · filed 2011-04-21 | $9.53M derived: sum of 2 quarters · filed 2012-02-17 | $9.17M derived: sum of 3 quarters · filed 2012-02-17 | ||||
| 2009-12-31 | $10.97M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-17 | $10.61M derived: sum of 2 quarters · filed 2012-02-17 | $7.84M 10-K · filed 2012-02-17 | ||||
| 2009-09-30 | -$358.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-22 | -$3.13M 10-Q · filed 2010-10-22 | |||||
| 2009-06-30 | -$2.77M 10-Q · filed 2010-07-23 | ||||||
| 2008-12-31 | $3.90M 10-K · filed 2011-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |